Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC005810

Drug Information
NameICI-118551
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(
14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3/t13-,16-/m1/s1
InChIKeyVFIDUCMKNJIJTO-CZUORRHYSA-N
Canonical SMILESCC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O    
Isomeric SMILESCC1=C2CCCC2=C(C=C1)OC[C@H]([C@@H](C)NC(C)C)O
TargetAdenosine A3 receptorInhibitor[1]
Beta-2 adrenergic receptorInhibitor[2]
Ref 1J Med Chem. 2005 Nov 3;48(22):6887-96.2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. To Reference
Ref 2J Med Chem. 2009 Mar 26;52(6):1773-7.Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543